At a glance
ClinicalIndex Comparison RecordN/ACompleted· 505 enrolled
Drug / intervention
active nicotine gum +1 moredrug
Likely dose
active nicotine gum 2 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cessation in Non-Daily Smokers: A RCT of NRT With Ecological Momentary Assessment
In Brief
A clinical study evaluating active nicotine gum and Standard behavioral therapy for Smoking. Completed, enrolled 505 participants across 1 site.
Detailed Summary
The purpose of this study is to examine the effect of as-needed oral Nicotine Replacement Therapy (NRT) - 2 mg nicotine gum - for smoking cessation in non-daily, or intermittent, smokers, and to study the process of relapse in ITS, using Ecological Momentary Assessment (EMA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJun 2014
Enrollment StartJun 2015
Primary CompletionJan 2019
TodayJul 2026
First PostedJun 20, 2014
Enrollment StartJun 1, 2015
Primary CompletionJan 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 12.0 years ago
Interventions
active nicotine gumdrug
2 mg, standard over-the-counter nicotine replacement therapy gum
Standard behavioral therapybehavioral
Standard behavioral therapy for smoking cessation